A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy

Prostate cancer (PCa) is the most common cancer in American men. Additionally, African American Men (AAM) are 60% more likely to be diagnosed with PCa and 2.4 times more likely to die from this disease compared to Caucasian men (CM). To date, there are few strategies effective for chemoprevention fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe, Dickinson, Shohreh, Schell, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147089/
https://www.ncbi.nlm.nih.gov/pubmed/32292572
http://dx.doi.org/10.18632/oncotarget.27529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147089/
https://www.ncbi.nlm.nih.gov/pubmed/32292572
http://dx.doi.org/10.18632/oncotarget.27529

Ejemplares similares